Relx NV (ADR)  

(Public, NYSE:RENX)   Watch this stock  
Find more results for RENX
-0.07 (-0.33%)
Feb 20 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 20.81 - 21.05
52 week 17.31 - 23.30
Open 20.92
Vol / Avg. 188,178.00/119,572.00
Mkt cap 43.51B
P/E 18.23
Div/yield 0.16/2.37
EPS 1.15
Shares 943.60M
Beta 0.64
Inst. own 1%

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 26.78% 22.66%
Operating margin 26.07% 26.05%
EBITD margin - 34.11%
Return on average assets 15.78% 13.02%
Return on average equity 91.18% 71.00%
Employees 30,000 -
CDP Score - -


Radarweg 29
+31-20-4852222 (Phone)
+31-20-4852032 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


RELX NV is a holding company, which holds interests in RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions. The Company's Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals progress science and advance healthcare. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry-specific content with technology and analytics. The Legal segment is a provider of information and analytics to professionals in legal, corporate, government and non-profit organizations. Its Exhibitions segment consists of Reed Exhibitions, which is an exhibitions business, with events in over 30 countries.

Officers and directors

Erik Engstrom Chief Executive Officer, Executive Director
Age: 53
Bio & Compensation  - Reuters
Nick L. Luff Chief Financial Officer, Executive Director
Age: 49
Bio & Compensation  - Reuters
Kumsal Bayazit Chairwoman, RELX Technology Forum and President, Exhibitions Europe
Bio & Compensation  - Reuters
Chet Burchett Chief Executive Officer Exhibitions
Bio & Compensation  - Reuters
Mark Kelsey Chief Executive Officer Risk Solutions and Business Analytics
Bio & Compensation  - Reuters
Ron Mobed Chief Executive Officer Scientific, Technical and Medical
Age: 57
Bio & Compensation  - Reuters
Mike Walsh Chief Executive Officer Legal
Bio & Compensation  - Reuters
Henry Adam Udow Chief Legal Officer and Company Secretary
Bio & Compensation  - Reuters
Wolfhart G. Hauser Senior Non-Executive Independent Director
Age: 67
Bio & Compensation  - Reuters
Ian R. Fraser Human Resources Director
Bio & Compensation  - Reuters